Estimating Demand and Unmet Need for Allogeneic Hematopoietic Cell Transplantation in the United States Using Geographic Information Systems-Reference-Cited by-同舟云学术

Estimating Demand and Unmet Need for Allogeneic Hematopoietic Cell Transplantation in the United States Using Geographic Information Systems

Published:2015-03 Issue:2 Volume:11 Page:e120-e130
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Besse Kelsey L.¹,Preussler Jaime M.¹,Murphy Elizabeth A.¹,Denzen Ellen M.¹,Lill Michael C.¹,Chell Jeffrey W.¹,Senneka Mary K.¹,Majhail Navneet S.¹,Williams Eric P.¹

Affiliation:

1. National Marrow Donor Program; Center for International Blood and Marrow Transplant Research, Minneapolis, MN; Cedars-Sinai Medical Center, Los Angeles, CA; and Cleveland Clinic, Cleveland, OH

Abstract

Market area maps and statistics developed using geographic information systems will help communicate the unmet need for HCTs, inform policy, and assist transplantation centers in planning for the anticipated growth in HCT use.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2014.000794

Reference26 articles.

1. Allogeneic Transplant Physician and Center Capacity in the United States

2. Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative

3. The National Marrow Donor Program’s Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment

4. GIS and Health Care

5. The role of GIS for health utilization studies: literature review

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop;Transplantation and Cellular Therapy;2024-09

2. Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers;Transplantation and Cellular Therapy;2023-08

3. Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia;Transplantation and Cellular Therapy;2022-12

4. Be the Match: Optimizing Capacity Allocation for Allogeneic Stem Cell Transplantation;Manufacturing & Service Operations Management;2022-11

5. Bibliometric analysis of cancer care operations management: current status, developments, and future directions;Health Care Management Science;2022-01-04